The sphingotest® DPP3 is a non-automated immunoluminometric assay (ILMA) for the in vitro diagnostic quantitative measurement of dipeptidyl peptidase 3 in human EDTA plasma.
Dipeptidyl peptidase…
The sphingotest® bio-ADM® is a non-automated immunoluminometric assay (ILMA) for the in vitro diagnostic quantitative measurement of bioactive Adrenomedullin 1-52 in human EDTA plasma.
Bioactive…
sphingotest® penKid® is a non-automated immunoluminometric assay (ILMA) for the in vitro diagnostic quantitative measurement of Proenkephalin A 119-159 in human EDTA plasma.
Proenkephalin A 119-159…
Follow our Journey on Social Media
View all Events
View all News
Events & Expos
Latest News
Subscribe to our Newsletter
Follow the link below to subscribe to our…
A new, improved formula has been developed for estimating the GFR using kidney function biomarker penKid. According to the data, penKid strongly correlates with the measured GFR (mGFR), while the…
A new study and real-world data on the kidney function biomarker penKid underline its potential to monitor kidney function during acute kidney injury (AKI) and RRT and to support liberation decisions…
The MDA solidifies the partnership between Boditech and SphingoTec, aiming to support the successful commercialization of the assay for the biomarker penKid on the AFIAS platforms.
For higher throughput, IVD tests for SphingoTec’s proprietary biomarkers for critical care and preventive medicine are made available as sphingotest® microtiterplate assays.
The global burden of sepsis world-wide counts for 49 million cases a year, with a high mortality rate of 11 million deaths. Recent research has identified new molecules that are informative and help…
